SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-025278
Filing Date
2022-11-01
Accepted
2022-11-01 09:20:12
Documents
14
Period of Report
2022-11-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20221031b_8k.htm   iXBRL 8-K 28726
2 EXHIBIT 99.1 ex_440124.htm EX-99.1 10322
  Complete submission text file 0001437749-22-025278.txt   178272

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pirs-20221101.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20221101_def.xml EX-101.DEF 11920
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20221101_lab.xml EX-101.LAB 15967
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20221101_pre.xml EX-101.PRE 12131
8 EXTRACTED XBRL INSTANCE DOCUMENT pirs20221031b_8k_htm.xml XML 2650
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 221348714
SIC: 2834 Pharmaceutical Preparations